Notice of Results and Nomination for AIM Awards

RNS Number : 6460Z

Inspiration Healthcare Group PLC

22 September 2020

 

Inspiration Healthcare Group plc

 ("Inspiration Healthcare", the "Company" or the "Group")

Notice of Results and Nomination for AIM Awards

Notice of Results

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company , will announce its unaudited interim results for the six months ended 31 July 2020 on Tuesday, 6 October 2020.  

Neil Campbell, Chief Executive Officer and Jon Ballard, Chief Financial Officer will deliver an online results presentation open to all existing and potential investors on Tuesday, 6 October 2020 at 9.30 am UK time.  The presentation will also allow for questions and answers and is expected to end at 11:00 am.

Details of the presentation and the access codes to attend will be forwarded to existing and potential investors who register their interest in advance with Alex Walters at Cadogan PR via email to [e-mail]

Investors will be able to submit questions before the event or at any time during the live presentation. 

Nomination for AIM Awards

Inspiration Healthcare has been shortlisted for the Best Use of AIM Award and the AIM Transaction of the Year Award in the 25^th AIM Awards sponsored by BDO in association with the London Stock Exchange. Voting will take place during November and December and details of the awards and voting can be seen at -  http://www.aim-awards.co.uk/

Enquiries:

Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Jon Ballard, Chief Financial Officer	Tel: [phone]
Nominated Adviser & Broker Cenkos Securities plc Mark Connelly Stephen Keys Cameron MacRitchie	Tel: [phone]
Cadogan PR  Alex Walters [e-mail]	Tel: [phone]

About Inspiration Healthcare Group

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping  resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired   Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables   and S.L.E., a   leading designer, manufacturer and global provider of neonatal ventilation products .  The Group generates approximately 60% of its revenues from export markets and around two-thirds of its revenues come from its own-branded products. 

With product availability actively promoted to over 75 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex).  The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport. Further information on Inspiration Healthcare can be found at   www.inspiration-healthcare.com

 

END

 

 

MSCVFLFLBKLBBBE